首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Establishment of a method to detect microalbuminuria by measuring the total urinary protein-to-creatinine ratio in diabetic patients.
【24h】

Establishment of a method to detect microalbuminuria by measuring the total urinary protein-to-creatinine ratio in diabetic patients.

机译:建立一种通过测量糖尿病患者总尿蛋白与肌酐比值来检测微量白蛋白尿的方法。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Diabetes and chronic kidney disease (CKD) which are risk facters of cardiovascular disease, are increasing global public health problems. Microalbuminuria is an early sign of progressive cardiovascular and renal disease in individuals with or without diabetes. Screening for microalbuminuria and early treatment are recommended for patients with increased cardiovascular and renal risk factors. However, the procedure used to measure urinary albumin is expensive. Alternatively, the measurement of total urinary protein is simple and inexpensive. Thus, we aimed to establish a method that could predict the presence of microalbuminuria by measuring the total protein-to-creatinine ratio. Spot urine samples were obtained from 150 patients with diabetes mellitus, and the total protein-to-creatinine ratio and the albumin-to-creatinine ratio (ACR) were measured. There was a significant positive correlation between the protein-to-creatinine ratio and the ACR (r = 0.95). The presence of albuminuria (both micro- and macroalbuminuria) could be predicted from the value of the protein-to-creatinine ratio in more than 90% of patients. A receiver-operating characteristic curve analysis revealed that the protein-to-creatinine ratio had a sensitivity and a specificity of 90.8% and 91.9%, respectively, for the detection of albuminuria and a cutoff value of 0.091 g/g creatinine. These results suggest that screening for microalbuminuria can be replaced by the detection of the protein-to-creatinine ratio, which may be cost-effective for patients with cardiovascular risks as well as for the general population.
机译:糖尿病和慢性肾脏病(CKD)是心血管疾病的危险因素,正在加剧全球公共卫生问题。微量白蛋白尿是患有或不患有糖尿病的个体进行性心血管疾病和肾脏疾病的早期迹象。对于心血管和肾脏危险因素增加的患者,建议筛查微量白蛋白尿并及早治疗。但是,用于测量尿白蛋白的方法很昂贵。可替代地,总尿蛋白的测量是简单且廉价的。因此,我们旨在建立一种可通过测量总蛋白与肌酐比率来预测微量白蛋白尿的存在的方法。从150例糖尿病患者中获取尿样,并测量总蛋白与肌酐之比和白蛋白与肌酐之比(ACR)。蛋白质与肌酐之比与ACR之间存在显着正相关(r = 0.95)。可以从90%以上的患者的蛋白与肌酐比值的值预测蛋白尿(微蛋白尿和大蛋白尿)的存在。接受者操作的特征曲线分析表明,蛋白与肌酐的比对检测白蛋白尿的敏感性和特异性分别为90.8%和91.9%,截断值为0.091 g / g肌酐。这些结果表明,通过检测蛋白与肌酐的比值可以代替对微量白蛋白尿的筛查,这对于患有心血管疾病的患者以及普通人群而言可能具有成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号